Oramed Pharmaceuticals Valuation
| ORMP Stock | USD 2.27 0.07 3.18% |
Based on Macroaxis valuation methodology, the company appears to be undervalued. Oramed Pharmaceuticals holds a recent Real Value of $2.67 per share. The prevailing price of the company is $2.27. Our model determines the value of Oramed Pharmaceuticals from analyzing the company fundamentals such as Shares Outstanding of 40.52 M, return on equity of 0.0324, and Operating Margin of (11.77) % as well as examining its technical indicators and probability of bankruptcy. In general, most investors support buying undervalued entities and selling overvalued entities since, at some point, asset prices and their ongoing real values will merge together. Key fundamental drivers impacting Oramed Pharmaceuticals' valuation include:
Price Book 0.6233 | Enterprise Value -22.2 M | Enterprise Value Ebitda (1.14) | Price Sales 76.2003 | Trailing PE 15.7143 |
Undervalued
Today
Please note that Oramed Pharmaceuticals' price fluctuation is very risky at this time. Calculation of the real value of Oramed Pharmaceuticals is based on 3 months time horizon. Increasing Oramed Pharmaceuticals' time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
Our valuation method for Oramed Pharmaceuticals is useful when determining the fair value of the Oramed stock, which is usually determined by what a typical buyer is willing to pay for full or partial control of Oramed Pharmaceuticals. Since Oramed Pharmaceuticals is currently traded on the exchange, buyers and sellers on that exchange determine the market value of Oramed Stock. However, Oramed Pharmaceuticals' intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 2.27 | Real 2.67 | Target 3.15 | Hype 2.27 |
The real value of Oramed Stock, also known as its intrinsic value, is the underlying worth of Oramed Pharmaceuticals Company, which is reflected in its stock price. It is based on Oramed Pharmaceuticals' financial performance, assets, liabilities, growth prospects, management team, or industry conditions. The intrinsic value of Oramed Pharmaceuticals' stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, news, and other external factors that may influence Oramed Pharmaceuticals' stock price. It is important to note that the real value of any stock may change over time based on changes in the company's performance.
Estimating the potential upside or downside of Oramed Pharmaceuticals helps investors to forecast how Oramed stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Oramed Pharmaceuticals more accurately as focusing exclusively on Oramed Pharmaceuticals' fundamentals will not take into account other important factors: Traditionally analysts and sophisticated investors use multiple methods for valuing a cash-flow-generating entity or its stock. For example, some money managers use Oramed Pharmaceuticals' intrinsic value based on its ongoing forecasts of Oramed Pharmaceuticals' financial statements. In contrast, other private, professional wealth advisors use a multiplier approach by looking to relative value analysis against Oramed Pharmaceuticals' closest peers. When choosing an evaluation method for Oramed Pharmaceuticals, ensure it is appropriate for the firm given its current financial situation and market classification. If more than one evaluation category is relevant, we suggest using both methods to arrive at a better estimate.
Oramed Pharmaceuticals Investments |
|
Oramed Valuation Trend
Knowing Oramed Pharmaceuticals' actual value is paramount for traders to make sound investment determinations. Oramed Pharmaceuticals' real value is not only important for the investor to make better decisions but also for a more accurate overall view of Oramed Pharmaceuticals' financial worth over time since having this information enables investors and analysts to forecast the earnings more efficiently. Using both Oramed Pharmaceuticals' enterprise value as well as its market capitalization is the best way to gauging the value of the company and is usually enough for investors to make market timing descisions.
Oramed Market Cap
Oramed Pharmaceuticals is rated below average in market capitalization category among related companies. Market capitalization of Health Care industry is now estimated at about 21.37 Billion. Oramed Pharmaceuticals adds roughly 89.14 Million in market capitalization claiming only tiny portion of equities under Health Care industry.Oramed Pharmaceuticals Valuation Ratios as Compared to Competition
Comparative valuation techniques use various fundamental indicators to help in determining Oramed Pharmaceuticals's current stock value. Our valuation model uses many indicators to compare Oramed Pharmaceuticals value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Oramed Pharmaceuticals competition to find correlations between indicators driving Oramed Pharmaceuticals's intrinsic value. More Info.Oramed Pharmaceuticals is rated below average in price to earning category among related companies. It is rated below average in price to book category among related companies . As of 04/19/2024, Price To Book Ratio is likely to grow to 2.92. Comparative valuation analysis is a catch-all model that can be used if you cannot value Oramed Pharmaceuticals by discounting back its dividends or cash flows. This model doesn't attempt to find an intrinsic value for Oramed Pharmaceuticals' Stock. Still, instead, it compares the stock's price multiples to a benchmark or nearest competition to determine if the stock is relatively undervalued or overvalued. The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Oramed Pharmaceuticals' earnings, one of the primary drivers of an investment's value.Please note that valuation analysis is one of the essential comprehensive assessments in business. It evaluates Oramed Pharmaceuticals' worth, which you can determine by considering its current assets, liabilities and future cash flows. The investors' valuation analysis is an important metric that will give you a perspective on different companies. It helps you know the worth of the potential investment in Oramed Pharmaceuticals and how it compares across the competition.
About Oramed Pharmaceuticals Valuation
The stock valuation mechanism determines the current worth of Oramed Pharmaceuticals on a weekly basis. We use both absolute as well as relative valuation methodologies to arrive at the intrinsic value of Oramed Pharmaceuticals. In general, an absolute valuation paradigm, as applied to this company, attempts to find the value of Oramed Pharmaceuticals based exclusively on its fundamental and basic technical indicators. By analyzing Oramed Pharmaceuticals's financials, quarterly and monthly indicators, and its related drivers such as dividends, operating cash flow, and various types of growth rates, we attempt to find the most accurate representation of Oramed Pharmaceuticals's intrinsic value. In some cases, mostly for established, large-cap companies, we also incorporate more traditional valuation methods such as dividend discount, discounted cash flow, or asset-based models. As compared to an absolute model, our relative valuation model uses a comparative analysis of Oramed Pharmaceuticals. We calculate exposure to Oramed Pharmaceuticals's market risk, different technical and fundamental indicators, relevant financial multiples and ratios, and then comparing them to Oramed Pharmaceuticals's related companies.| Last Reported | Projected for Next Year | ||
| Gross Profit | 3.1 M | 3.3 M | |
| Pretax Profit Margin | (12.54) | (13.17) | |
| Operating Profit Margin | (17.27) | (16.41) | |
| Net Loss | (12.57) | (13.20) | |
| Gross Profit Margin | 0.87 | 0.65 |
8 Steps to conduct Oramed Pharmaceuticals' Valuation Analysis
Company's valuation is the process of determining the worth of any company in monetary terms. It estimates Oramed Pharmaceuticals' potential worth based on factors such as financial performance, market conditions, growth prospects, and overall economic environment. The result of company valuation is a single number representing a Company's current market value. This value can be used as a benchmark for various financial transactions such as mergers and acquisitions, initial public offerings (IPOs), or private equity investments. To conduct Oramed Pharmaceuticals' valuation analysis, follow these 8 steps:- Gather financial information: Obtain Oramed Pharmaceuticals' financial statements, including balance sheets, income statements, and cash flow statements.
- Determine Oramed Pharmaceuticals' revenue streams: Identify Oramed Pharmaceuticals' primary sources of revenue, including products or services offered, target markets, and pricing strategies.
- Analyze market data: Research Oramed Pharmaceuticals' industry and market trends, including the size of the market, growth rate, and competition.
- Establish Oramed Pharmaceuticals' growth potential: Evaluate Oramed Pharmaceuticals' management, business model, and growth potential.
- Determine Oramed Pharmaceuticals' financial performance: Analyze its financial statements to assess its historical performance and future potential.
- Choose a valuation method: Consider the Company's specific circumstances and choose an appropriate valuation method, such as the discounted cash flow (DCF) or comparable analysis method.
- Calculate the value: Apply the chosen valuation method to the financial information and market data to calculate Oramed Pharmaceuticals' estimated value.
- Review and adjust: Review the results and make necessary adjustments, considering any relevant factors that may have been missed or overlooked.
Oramed Pharmaceuticals Growth Indicators
Growth stocks usually refer to those companies expected to grow sales and earnings faster than the market average. Growth stocks typically don't pay dividends, often look expensive, and usually trading at a high P/E ratio. Nevertheless, such valuations could be relatively cheap if the company continues to grow, which will drive the share price up. However, since most investors are paying a high price for a growth stock, based on expectations, if those expectations are not fully realized, growth stocks can see dramatic declines. Note, investing in growth stocks can be very risky. If the company such as Oramed Pharmaceuticals does not do well, investors take a loss on the stock when it is time to sell. Also, because growth stocks typically do not pay dividends, the only opportunity an investor has to make money on their investment is when they eventually sell their shares.
| Common Stock Shares Outstanding | 39 M |
Oramed Pharmaceuticals Current Valuation Indicators
Valuation refers to the process of determining the present value of Oramed Pharmaceuticals and all of its assets. It can be calculated using a number of techniques. As many analysts who try to value Oramed we look at many different elements of the entity such as Oramed's management, its prospective future earnings, the current market value of the company's assets, as well as its capital structure formation. Oramed Pharmaceuticals' valuation analysis is also a process of estimating the intrinsic value of all assets and outstanding equities. There are different methodologies and models we use to develop the final Oramed Pharmaceuticals' valuation. The techniques such as discounted cash flow and fundamental indicators such as book value per share or market capitalization are well known and widely used across most financial advisers and money managers.
Valuations are an essential part of business, for companies themselves, but also for investors. For companies, such as Oramed Pharmaceuticals, valuations can help measure their progress and success and can help them track their performance in the market compared to others. In addition, investors can use Oramed Pharmaceuticals' valuations to help determine the worth of potential investments. They can do this by using data and information made public by a company. Regardless of who the valuation is for, it essentially describes Oramed Pharmaceuticals' worth.When determining whether Oramed Pharmaceuticals is a good investment, qualitative aspects like company management, corporate governance, and ethical practices play a significant role. A comparison with peer companies also provides context and helps to understand if Oramed Stock is undervalued or overvalued. This multi-faceted approach, blending both quantitative and qualitative analysis, forms a solid foundation for making an informed investment decision about Oramed Pharmaceuticals Stock. Highlighted below are key reports to facilitate an investment decision about Oramed Pharmaceuticals Stock: Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in Oramed Pharmaceuticals. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in population. To learn how to invest in Oramed Stock, please use our How to Invest in Oramed Pharmaceuticals guide.You can also try the Stocks Directory module to find actively traded stocks across global markets.
Complementary Tools for Oramed Stock analysis
When running Oramed Pharmaceuticals' price analysis, check to measure Oramed Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Oramed Pharmaceuticals is operating at the current time. Most of Oramed Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Oramed Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Oramed Pharmaceuticals' price. Additionally, you may evaluate how the addition of Oramed Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.
| Top Crypto Exchanges Search and analyze digital assets across top global cryptocurrency exchanges | |
| Technical Analysis Check basic technical indicators and analysis based on most latest market data | |
| Pattern Recognition Use different Pattern Recognition models to time the market across multiple global exchanges | |
| Portfolio Dashboard Portfolio dashboard that provides centralized access to all your investments | |
| Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios. | |
| Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets | |
| Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets | |
| Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings |
Is Oramed Pharmaceuticals' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Oramed Pharmaceuticals. If investors know Oramed will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Oramed Pharmaceuticals listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share 0.14 | Revenue Per Share 0.033 | Quarterly Revenue Growth (1.00) | Return On Assets (0.05) | Return On Equity 0.0324 |
The market value of Oramed Pharmaceuticals is measured differently than its book value, which is the value of Oramed that is recorded on the company's balance sheet. Investors also form their own opinion of Oramed Pharmaceuticals' value that differs from its market value or its book value, called intrinsic value, which is Oramed Pharmaceuticals' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Oramed Pharmaceuticals' market value can be influenced by many factors that don't directly affect Oramed Pharmaceuticals' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Oramed Pharmaceuticals' value and its price as these two are different measures arrived at by different means. Investors typically determine if Oramed Pharmaceuticals is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Oramed Pharmaceuticals' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.